UTMB-Novartis Alliance for Pandemic Preparedness
UTMB-诺华流行病防范联盟
基本信息
- 批准号:10845855
- 负责人:
- 金额:$ 1884.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-16 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcademiaAirAntiviral AgentsBiologyCOVID-19COVID-19 assayCOVID-19 pandemicCellsCessation of lifeClinicalCollaborationsCommunicable DiseasesCommunicationComplexCoronavirusDataDecision MakingDengueDevelopmentDiagnosticDrug TargetingEducationEmerging TechnologiesEnsureFacultyFamilyFlavivirusFoundationsFutureGenerationsGoalsHendra VirusHenipavirusHomeHumanHumanitiesIndustryInfectionInstitutionIntellectual PropertyInvestmentsLaboratoriesLearningLibrariesLifeMachine LearningMarketingMedicalMedicineMembrane ProteinsMentorsMiddle East Respiratory Syndrome CoronavirusNipah VirusNongovernmental OrganizationsNucleosidesNucleotidesOralPeptide HydrolasesPharmaceutical PreparationsPharmacologic SubstancePhase I Clinical TrialsPhenotypePolymerasePopulation DensityPostdoctoral FellowPredispositionPrivate SectorPrivatizationProbabilityProcessProductivityProtease InhibitorQuantitative Structure-Activity RelationshipRNA-Directed RNA PolymeraseRationalizationResearchResearch ActivityResearch Project GrantsResistanceSARS-CoV-2 inhibitorSeasonsSerotypingSpanish fluTechnologyTexasTrainingTranslational ResearchTravelUnited States National Institutes of HealthUniversitiesVaccinesViralVirusbiosafety level 4 facilityclinical candidateclinical investigationcombatdrug candidatedrug discoveryeconomic costinhibitorinnovationmortalitymultidisciplinarynew technologynext generationnovelpandemic diseasepandemic potentialpandemic preparednessprevent pandemicsprogramspublic health relevancepublic-private partnershiprecruitresponserole modelscreeningstudent trainingsuccesssynergismtranslational impactviral pandemicvirology
项目摘要
OVERALL – ABSTRACT
Pandemic prevention and preparedness is a major scientific and societal priority that requires sustained and
forward looking investments across governmental, non-governmental, academic and private sectors to develop
an arsenal of countermeasures against the existential threat of viral pandemics. Combining world-leading
BSL3/4 capabilities at University of Texas of Medical Branch (UTMB) and state-of-the art drug discovery
technologies at Novartis, the UTMB Novartis Alliance for Pandemic Preparedness (UNAPP), is a unique
and innovative partnership that brings together the multi-disciplinary expertise required to deliver high quality
antiviral drug candidates. Enabled by world-leading virologists and seasoned drug hunters, UNAPP will
aggressively prosecute a portfolio of 5 projects aiming to discover orally available, safe, and effective drugs
against coronaviruses, flavivirus and henipavirus, three major classes of viruses with pandemic
potential. The projects portfolio combines approaches targeting well validated drug targets, such as the RNA-
dependent RNA polymerases and viral proteases, as well as phenotypic screening, which will allow for the
discovery of clinical drug candidates and novel targets that will advance our fundamental understanding of the
biology of those viruses. Four scientific Cores—Virology, High-Throughput Biology, Drug Discovery and
Translational Research Cores—will provide technological and scientific expertise to support Project Teams and
implement the scientific strategy toward novel antiviral drugs. The UNAPP will be governed by an Administrative
Core which will be co-led by the PIs, Dr. Pei-Yong Shi and Dr. Thierry Diagana, who have a long track-record of
successfully working together. Both PIs have led multiple productive collaborations focused on translational
impact and combining public, private and non-governmental organizations. The Administrative Core will provide
integrated decision making in scientific, operational, financial, intellectual property protection, and
communication. In collaboration with all project and Core leaders, as well as with external input from a Scientific
Advisory Board and NIH program officers, they will ensure that the projects portfolio leverages the full spectrum
of technologies and capabilities residing in all four scientific Cores, capturing synergies across projects through
cross-learning and efficient deployment of platforms relevant to multiple viruses. Because of the unique
complementarity of the scientific Cores and the remarkable synergies of the project portfolio, we fully expect that
the UNAPP will yield exceptional productivity and deliver all the proposed objectives: (1) Deliver 3 IND-ready
candidates and 3 Development Candidates, (2) advance antiviral research, and (3) train next-generation
drug hunters.
总体-摘要
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reverse genetic systems of SARS-CoV-2 for antiviral research.
- DOI:10.1016/j.antiviral.2022.105486
- 发表时间:2023-02
- 期刊:
- 影响因子:7.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thierry Diagana其他文献
Thierry Diagana的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thierry Diagana', 18)}}的其他基金
UTMB-Novartis Alliance for Pandemic Preparedness
UTMB-诺华流行病防范联盟
- 批准号:
10514146 - 财政年份:2022
- 资助金额:
$ 1884.9万 - 项目类别:
相似海外基金
Conference: Rethinking how language background is described in academia and beyond
会议:重新思考学术界及其他领域如何描述语言背景
- 批准号:
2335912 - 财政年份:2024
- 资助金额:
$ 1884.9万 - 项目类别:
Standard Grant
ADVANCE Catalyst: Virtual Observatory of Culture for Equity in Academia at the University of Puerto Rico Rio Piedras (VoCEA)
ADVANCE Catalyst:波多黎各 Rio Piedras 大学学术界平等文化虚拟观察站 (VoCEA)
- 批准号:
2214418 - 财政年份:2023
- 资助金额:
$ 1884.9万 - 项目类别:
Standard Grant
Comprehensive development strategy of modality-specific "intellectual property" and "cultivation" with an eye on "pharmaceutical affairs" in academia drug discovery
学术界新药研发着眼“药事”的模式“知识产权”与“培育”综合发展策略
- 批准号:
23K02551 - 财政年份:2023
- 资助金额:
$ 1884.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating Research Advancement for Investigators Underrepresented in Academia
加速学术界代表性不足的研究人员的研究进展
- 批准号:
10746315 - 财政年份:2023
- 资助金额:
$ 1884.9万 - 项目类别:
Planning: HBCU-UP: Strengthening Data Science Research Capacity and Education Programs through Academia-Industry Partnership
规划:HBCU-UP:通过学术界与工业界合作加强数据科学研究能力和教育计划
- 批准号:
2332161 - 财政年份:2023
- 资助金额:
$ 1884.9万 - 项目类别:
Standard Grant
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
从学术界到商界:针对 HPV 相关癌症的新型疗法的开发
- 批准号:
10813323 - 财政年份:2023
- 资助金额:
$ 1884.9万 - 项目类别:
Academics4Rail: Building a community of railway scientific researchers and academia for ERJU and enabling a network of PhDs (academia teaming with industry)
Academys4Rail:为ERJU建立铁路科研人员和学术界社区并建立博士网络(学术界与工业界合作)
- 批准号:
10087488 - 财政年份:2023
- 资助金额:
$ 1884.9万 - 项目类别:
EU-Funded
Academics4Rail: Building a Community of Railway Scientific Researchers and Academia for ERJU and Enabling a Network of PhDs (Academia Teaming with Industry)
Academys4Rail:为二院建立铁路科研人员和学术界社区并启用博士网络(学术界与工业界合作)
- 批准号:
10102850 - 财政年份:2023
- 资助金额:
$ 1884.9万 - 项目类别:
EU-Funded
Exploring the overall picture of industry-academia-government collaboration: A spectrum of knowledge transfer through formal and informal channels
探索产学官合作的整体图景:通过正式和非正式渠道进行的一系列知识转移
- 批准号:
22K01692 - 财政年份:2022
- 资助金额:
$ 1884.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project
促进道德神经技术学术界与工业界的伙伴关系:利益相关者参与和工具包开发项目
- 批准号:
10655632 - 财政年份:2022
- 资助金额:
$ 1884.9万 - 项目类别:














{{item.name}}会员




